IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximab.
Magdelaine-Beuzelin C, Vermeire S, Goodall M, Baert F, Noman M, Assche GV, Ohresser M, Degenne D, Dugoujon JM, Jefferis R, Rutgeerts P, Lefranc MP, Watier H.
Magdelaine-Beuzelin C, et al. Among authors: watier h.
Pharmacogenet Genomics. 2009 May;19(5):383-7. doi: 10.1097/FPC.0b013e32832a06bf.
Pharmacogenet Genomics. 2009.
PMID: 19319024